Amoxicillin high-dose dual therapy for Helicobacter pylori primary eradication: Proton pump inhibitor and potassium-competitive acid blocker, which’s better?

Table 6 Univariate analysis of factors related to eradication rates, n (%)

Variables	14d-EA group and 14d-B-quadruple group (n = 353)		14d-VA group and 14d-VAC group (n = 325)
	Eradication rate (success/total)	P value	Eradication rate (success/total)	P value
Gender
Male	151/158 (95.57)	0.879	141/149 (94.63)	0.902
Female	187/195 (95.90)		166/176 (94.32)
Age
≤ 60 years	319/333 (95.80)	0.591	278/295 (94.24)	0.892
> 60 years	19/20 (95.00)		29/30 (96.67)
Fixed occupation
Yes	209/219 (95.43)	0.706	184/194 (94.85)	0.713
No	129/134 (96.27)		123/131 (93.89)
BMI, kg/m²
< 22	116/123 (94.31)	0.271	128/136 (94.12)	0.092
22-25	140/147 (95.24)		116/119 (97.48)
> 25	82/83 (98.80)		63/70 (90.00)
BSA, m²
< 1.65	171/181 (94.48)	0.223	174/184 (94.57)	0.926
≥ 1.65	167/172 (97.09)		133/141 (94.33)
Education status
Primary	28/30 (93.33)	0.280	25/26 (96.15)	0.954
Junior high school	45/47 (95.74)		38/40 (95.00)
High school	54/58 (93.10)		58/61 (95.08)
College	154/161 (95.65)		140/148 (94.59)
Above university	57/57 (100.00)		46/50 (92.00)
Place of residence
Urban area	278/285 (97.54)	0.001a	252/263 (95.82)	0.004a
Suburban area	36/43 (83.72)		31/38 (81.58)
Rural area	24/25 (96.00)		24/24 (100.00)
Smoking
Yes	85/89 (95.51)	1.000	75/80 (93.75)	0.969
No	253/264 (95.83)		232/245 (94.69)
Drinking
Frequent	21/22 (95.45)	0.822	18/19 (94.74)	0.768
Occasional	89/92 (96.74)		81/87 (93.10)
None	228/239 (95.40)		208/219 (94.98)
Past medical history
Yes	59/61 (96.72)	0.949	53/55 (96.36)	0.724
No	279/292 (95.55)		254/270 (94.07)
Family infection of H. pylori
Yes	108/112 (96.43)	0.895	86/93 (92.47)	0.449
No	126/132 (95.45)		129/134 (96.27)
Undetected	104/109 (95.41)		92/98 (93.88)
Digestive symptoms
Yes	256/268 (95.52)	0.945	246/259 (94.98)	0.611
No	82/85 (96.47)		61/66 (92.42)
Endoscopy diagnosis
Yes	230/242 (95.04)	0.489	205/219 (93.61)	0.333
No	108/111 (97.30)		102/106 (96.23)
Atrophic gastritis
Yes	62/65 (95.38)	1.000	59/63 (93.65)	0.995
No	276/288 (95.83)		248/262 (94.66)
History of antibiotics use in 2 years
Yes	170/183 (92.90)	0.006a	150/165 (90.91)	0.004a
No	168/170 (98.82)		157/160 (98.13)
Relief of symptoms
No symptoms	82/85 (96.47)	0.418	61/66 (92.42)	0.318
Remission	173/184 (94.02)		161/168 (95.83)
Symptoms disappeared	69/70 (98.57)		71/75 (94.67)
No	14/14 (100.00)		14/16 (87.50)
Adverse events
Yes	21/21 (100.00)	1.000	31/33 (93.94)	1.000
No	317/332 (95.48)		276/292 (94.52)
Compliance
Good	337/350 (96.29)	0.005a	299/314 (95.22)	0.018a
Poor	1/3 (33.33)		8/11 (72.73)

^aP < 0.05.

BMI: Body mass index; BSA: Body surface area; EA: Esomeprazole-amoxicillin; B-quadruple: Esomeprazole-amoxicillin-clarithromycin-bismuth; VA: Vonoprazan-amoxicillin; VAC: Vonoprazan-amoxicillin-clarithromycin.